HH&L Acquisition Co.

CIK: 1824185•Ticker: HHLA

SPAC Overview

$414M
IPO Size
$44.8M
Trust (as of 2023-09-30)
Failed
Current Status
2021
IPO Year

Timeline Progress

About

HH&L Acquisition Co. is a blank-check company seeking a business combination, with a stated focus on healthcare or healthcare-related companies in Asian markets, particularly Greater China, and global healthcare businesses with meaningful growth in Greater China or Asian markets.

Investment Focus

Healthcare

Geographic Focus

Asian markets, Greater China

Embarc dashboard

What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.

  • Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
  • Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
  • The full 8-K lifecycle timeline, each event linked to its filing
  • Price history across the unit, share and warrant tickers
  • Follow it, and see it change on your watchlist
Open in the dashboard

SPAC Team

Extended Team Information

Led by Kenneth W. Hitchner, Richard Qi Li, Huanan Yang and Yingjie (Christina) Zhong, with advisory-board chairman Fenglei Fang. The team describes experience in healthcare, investing, capital markets and cross-border transactions, and will receive support from HOPU Investments.

Key Information

IPO Date
2021-02-08
Total Redemptions
$319M
SIC
6770
Failed Date
2024-02-23
SPAC Ticker
HHLA